Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page
- Check2 days agoChange DetectedThe site shows a revision update from v3.4.1 to v3.4.2. No changes to core study details or navigation are observed.SummaryDifference0.0%

- Check10 days agoChange DetectedA new revision tag (v3.4.1) was added and the previous revision (v3.4.0) removed; there are no changes to the study content or visible page information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.4 was added and the previous Revision: v3.3.3 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedLocations section expanded to include new regional sites across the US and internationally (Arizona, California, Florida, Michigan, New York, North Carolina, Oklahoma, Tennessee, Texas, South Australia, Victoria, Nova Scotia, Ontario, Emilia-Romagna, Lombardy, Mexico City, Nuevo León, Sankt-Peterburg, Alicante, Barcelona) and updated to v3.3.3; some previous location groupings were removed.SummaryDifference2%

- Check83 days agoChange DetectedThe page shows a new revision label 'Revision: v3.3.2' in place of the previous 'Revision: v3.2.0'. This looks like a frontend update and does not modify study details or other substantive content.SummaryDifference0.0%

- Check90 days agoChange DetectedRemoved the top banner notice about government funding and operating status, which does not affect the study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.